PFProf. Eitan Friedman
Director and founder of the Suzanne Levy-Gertner Oncogenetics Unit · Director
At a glance
Core facts about the doctor and the hospital, as provided by the hospital.
1 areaSpecialties: Pediatric Hemato - Oncology
PediatricsCategory
English, HebrewLanguages
JCIAccredited hospital · Tel Hashomer
72 staffListed at this hospital
Dr. Golan Hana is a Deputy Director of the Pediatric Hemato-Oncology and BMT Division at Sheba Medical Center in Tel Hashomer, Israel, a JCI-accredited center. Lists Pediatric Hemato - Oncology.
About
Dr Hana Golan serves as the deputy director and the head of the day care service of the Pediatric Hematology Oncology division. She completed her medical degree at the Technion- Israel Institute of Technology and specialized in pediatrics and pediatric hemato-oncology at the Safra Children’s Hospital at the Sheba Medical Center. Dr. Golan has a special interest in treating children with Neuroblastoma and serves as the PI of the international HR ESIOP protocol in the department.
Main research areas:
Isolation and characterization of cancer stem cells from various pediatric solid tumors
Development of new treatments designed to target and destroy cancer stem cells.
The effects of cannabinoids on pediatric tumors
TEACHING
Coordinator of the Hematology course for medical students, Sackler Faculty of Medicine at Tel Aviv University, Israel, 2009-2011
Pediatric Hematology oncology lectures for medical students and nurses,
1996 – Present.
Tutor in charge of medical students, 1991-1992
PROJECTS
· Director of the computerized program of the inpatient and outpatient computerized medical record
· Establishment of computerized chemotherapy protocols and patient’s database, 1999 – 2014.
CLINICAL TRIALS EXPERIENCE
Principle investigator of the High Risk Neuroblastoma 1.7 ESIOP protocol, Sheba medical center, 2002 – present.
Principle investigator of the “Phase I/II, 2-part, Multi Center, Single arm, Open-Label Study, to determine the Safety, Tolerability and Pharmacokinetics of oral Dabrafenib in Children and Adolescent Subjects with Advanced BRAF V-600 Mutation Positive Solid Tumors. 2015-2016
Principle investigator of the “Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder” 2013-2015
· National coordinator of the High Risk Neurobl
Main research areas:
Isolation and characterization of cancer stem cells from various pediatric solid tumors
Development of new treatments designed to target and destroy cancer stem cells.
The effects of cannabinoids on pediatric tumors
TEACHING
Coordinator of the Hematology course for medical students, Sackler Faculty of Medicine at Tel Aviv University, Israel, 2009-2011
Pediatric Hematology oncology lectures for medical students and nurses,
1996 – Present.
Tutor in charge of medical students, 1991-1992
PROJECTS
· Director of the computerized program of the inpatient and outpatient computerized medical record
· Establishment of computerized chemotherapy protocols and patient’s database, 1999 – 2014.
CLINICAL TRIALS EXPERIENCE
Principle investigator of the High Risk Neuroblastoma 1.7 ESIOP protocol, Sheba medical center, 2002 – present.
Principle investigator of the “Phase I/II, 2-part, Multi Center, Single arm, Open-Label Study, to determine the Safety, Tolerability and Pharmacokinetics of oral Dabrafenib in Children and Adolescent Subjects with Advanced BRAF V-600 Mutation Positive Solid Tumors. 2015-2016
Principle investigator of the “Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder” 2013-2015
· National coordinator of the High Risk Neurobl
Education
- MD, the Rappaport School of Medicine, Technion, Haifa, Israel 1981 – 1988.Residency, Department of Pediatrics, the Chaim Sheba Medical Center, Israel, 1989 –1993Residency, Department of Pediatric Hematology –Oncology, the Chaim Sheba Medical Center, Israel, 1996 – 1999Cancer in Children: challenges and controversies. The British Council international seminar, London, England, 1997.Basic Research: Tolerance Mechanisms in Transplantation, Professor Yair Reisner Laboratory, Immunology Department, Weizmann Institute, Israel, 2006-2008.GCP course: Sheba Medical Center, Israel, 2008.Advanced management program for senior hematologists, LAHAV Executive Education, Tel-Aviv university, 2010Debriefing Assessment in Healthcare For Promoting Patient Safety, Sheba Medical Center, 2014Biomedical Informatics - Diploma Studies for Physicians and Senior Researchers, Bar-Ilan University, 2014-2015
Memberships
Israel Medical Association, Israel Society of Pediatric Hematology Oncology, Israel Society of Hematology and Blood Transfusions
Ask the doctor's team about your case
Send your reports and questions to Sheba Medical Center. The hospital replies through Health-Tourism.com.
Free consultation • No obligation • Direct communication with the hospital
